← Back to Search

Treatment for Sarcopenia (M&M Trial)

N/A
Recruiting
Led By Grant R Williams, MD
Research Sponsored by Wake Forest University Health Sciences
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This study will examine the association between low muscle mass (myopenia) at diagnosis and chemotherapy toxicity in older adults with newly diagnosed advanced colorectal cancer.

Eligible Conditions
  • Sarcopenia
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Chemotherapy Toxicities (Grade 3 - 5)
Secondary study objectives
Overall Survival

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,361 Previous Clinical Trials
1,039,709 Total Patients Enrolled
2 Trials studying Sarcopenia
72 Patients Enrolled for Sarcopenia
University of Alabama at BirminghamOTHER
1,635 Previous Clinical Trials
2,304,859 Total Patients Enrolled
3 Trials studying Sarcopenia
207 Patients Enrolled for Sarcopenia
Grant R Williams, MDPrincipal InvestigatorUniversity of Alabama at Birmingham
~10 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top